PanGen Biotech Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.pangen.com

Country

South Korea

Exchange

KOSDAQ

Founded 1999

PanGen Biotech is a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc, as well as CHO cell lines for proteins and monoclonal antibodies

One-stop services ranging from producer cell line development to GMP production. Additionally, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. Founded in 1999, PanGen Biotech is based in Suwon-si, South Korea.

Key Stats

52-Week Range

₩4220.00₩8510.00

Beta-0.10

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.